Reverse Or Nothing For Complex Proximal Humeral Fractures
Primary Purpose
Humeral Fractures
Status
Completed
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Reverse shoulder arthroplasty
Sponsored by
About this trial
This is an interventional treatment trial for Humeral Fractures focused on measuring Conservative treatment, Reverse shoulder arthroplasty, Proximal humeral fractures
Eligibility Criteria
Inclusion Criteria:
- Patients with mental conditions available for rehabilitation protocols
- Patients presenting a 3 or 4 part proximal humeral fracture
Exclusion Criteria:
- Extremely displaced fractures with no bony contact or less than 1 cm.
- Cognitive impairment (Pfeiffer test >3)
- Shoulder dislocations
- Unable to sign informed consent or unable to respond to questionnaires
- Trauma or previous surgery of the extremity
- Open or pathological fracture
- Vascular or neurological injury associated
- Unable to collaborate with rehabilitation
- Patients with serious comorbidities that discourage surgery
Sites / Locations
- Joan Miquel Noguera
Arms of the Study
Arm 1
Arm 2
Arm Type
No Intervention
Experimental
Arm Label
CONSERVATIVE TREATMENT
REVERSE ARTHROPLASTY TREATMENT
Arm Description
Conservative treatment is conceived to the use of sling for three weeks, followed by rehabilitation protocol
This group receives a surgical intervention by the use of reverse shoulder arthroplasty through deltopectoral approach and tuberosities reattachment. It is followed by the same rehabilitation protocol than conservative treatment
Outcomes
Primary Outcome Measures
Pain, Mobility, Strenght and Daily Life Activities. (Functional Outcome)
Constant-Murley Score. The Constant-Murley score (CMS) is a 100-points scale composed of a number of individual parameters. These parameters define the level of pain and the ability to carry out the normal daily activities of the patient.The Constant-Murley score was introduced to determine the functionality after the treatment of a shoulder injury and it ranges from 0 to 100 points. The test is divided into four subscales: pain (0 to 15 points), activities of daily living (0 to 20 points), strength (0 to 25 points) and range of motion: forward elevation (0 to 10 points), external rotation (o to 10 points), abduction (0 to 10 points) and internal rotation of the shoulder (0 to 10 points). Then, those range of motion items allocate from 0 to 40 points to the global score.
The higher the score, the higher the quality of the function.
Secondary Outcome Measures
Number of participants with treatment-related surgical reinterventions
Number of participants with treatment-related adverse events that require an additional surgical treatment after the randomization; such as debridement, implant replacement In the control group; reinterventions will be measured by the necessity to receive a treatment for fracture sequelae such as an implantation of a shoulder prosthesis or any other surgical intervention
Number of participants with treatment-related shoulder joint infection
Acute infection will be defined as swelling, erythema, fever, purulent discharge or increasing level of biological parameters such as C-reactive protein (CRP), white blood cell count (WBC).
Only expected in experimental/intervention group
Number of participants with treatment-related Implant dislocation
It is defined as the number of patients in experimental arm presenting a radiological disalignement between the humeral component (stem) and the glenoid component (glenosphere).
Only expected in experimental/intervention group
Full Information
NCT ID
NCT03610113
First Posted
July 16, 2018
Last Updated
August 28, 2023
Sponsor
Consorci Sanitari de l'Anoia
Collaborators
Germans Trias i Pujol Hospital, Parc de Salut Mar
1. Study Identification
Unique Protocol Identification Number
NCT03610113
Brief Title
Reverse Or Nothing For Complex Proximal Humeral Fractures
Official Title
Reverse Shoulder Arthroplasty Versus Conservative Treatment For Complex Proximal Fractures in Elderly Patients
Study Type
Interventional
2. Study Status
Record Verification Date
August 2023
Overall Recruitment Status
Completed
Study Start Date
September 2016 (Actual)
Primary Completion Date
August 2023 (Actual)
Study Completion Date
August 2023 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Consorci Sanitari de l'Anoia
Collaborators
Germans Trias i Pujol Hospital, Parc de Salut Mar
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Reverse shoulder prosthesis has recently emerged as an acute treatment for complex proximal humeral fractures. Promising functional results have been reported in observational papers.
However, no clinical trials have yet been reported when comparing the conservative treatment to surgical treatment through the use of reverse shoulder arthroplasty.
Detailed Description
Introduction The proximal humeral fractures are frequent in the investigator's environment. Among them, about 20% are considered as complex features. Conservative treatment has traditionally offered an extensive range of results. The reverse shoulder prosthesis as a treatment for acute fractures of the proximal humeral in the elderly population has changed the therapeutic approach of this acute pathology. However, high-level evidence-based studies are still not available, when comparing the conservative treatment with the treatment with reverse shoulder prosthesis.
Objective To compare the functional results and complications of elderly patients presenting acute complex fractures of the proximal humerus through two types of treatments; conservative treatment and treatment with reverse shoulder prosthesis.
Methodology A prospective, multicentre and randomized study comparing conservative treatment with the surgical treatment at two years followup by the use of functional shoulder assessment (Constant scale), complications and re-interventions associated with each treatment. The quality of life will also be analyzed through the SF-36 health questionnaire
Expected results The null hypothesis of the work is based on the appearance of non-significant differences between the two groups of the study (conservative vs. surgical treatment), concerning functional status, complications, and re-interventions
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Humeral Fractures
Keywords
Conservative treatment, Reverse shoulder arthroplasty, Proximal humeral fractures
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
InvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
81 (Actual)
8. Arms, Groups, and Interventions
Arm Title
CONSERVATIVE TREATMENT
Arm Type
No Intervention
Arm Description
Conservative treatment is conceived to the use of sling for three weeks, followed by rehabilitation protocol
Arm Title
REVERSE ARTHROPLASTY TREATMENT
Arm Type
Experimental
Arm Description
This group receives a surgical intervention by the use of reverse shoulder arthroplasty through deltopectoral approach and tuberosities reattachment.
It is followed by the same rehabilitation protocol than conservative treatment
Intervention Type
Device
Intervention Name(s)
Reverse shoulder arthroplasty
Other Intervention Name(s)
Shoulder prosthesis
Intervention Description
The implantation of reverse shoulder prosthesis, and reattachment of greater and lesser tuberosities
Primary Outcome Measure Information:
Title
Pain, Mobility, Strenght and Daily Life Activities. (Functional Outcome)
Description
Constant-Murley Score. The Constant-Murley score (CMS) is a 100-points scale composed of a number of individual parameters. These parameters define the level of pain and the ability to carry out the normal daily activities of the patient.The Constant-Murley score was introduced to determine the functionality after the treatment of a shoulder injury and it ranges from 0 to 100 points. The test is divided into four subscales: pain (0 to 15 points), activities of daily living (0 to 20 points), strength (0 to 25 points) and range of motion: forward elevation (0 to 10 points), external rotation (o to 10 points), abduction (0 to 10 points) and internal rotation of the shoulder (0 to 10 points). Then, those range of motion items allocate from 0 to 40 points to the global score.
The higher the score, the higher the quality of the function.
Time Frame
1 year
Secondary Outcome Measure Information:
Title
Number of participants with treatment-related surgical reinterventions
Description
Number of participants with treatment-related adverse events that require an additional surgical treatment after the randomization; such as debridement, implant replacement In the control group; reinterventions will be measured by the necessity to receive a treatment for fracture sequelae such as an implantation of a shoulder prosthesis or any other surgical intervention
Time Frame
1 year
Title
Number of participants with treatment-related shoulder joint infection
Description
Acute infection will be defined as swelling, erythema, fever, purulent discharge or increasing level of biological parameters such as C-reactive protein (CRP), white blood cell count (WBC).
Only expected in experimental/intervention group
Time Frame
1 year
Title
Number of participants with treatment-related Implant dislocation
Description
It is defined as the number of patients in experimental arm presenting a radiological disalignement between the humeral component (stem) and the glenoid component (glenosphere).
Only expected in experimental/intervention group
Time Frame
1 year
10. Eligibility
Sex
All
Minimum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients with mental conditions available for rehabilitation protocols
Patients presenting a 3 or 4 part proximal humeral fracture
Exclusion Criteria:
Extremely displaced fractures with no bony contact or less than 1 cm.
Cognitive impairment (Pfeiffer test >3)
Shoulder dislocations
Unable to sign informed consent or unable to respond to questionnaires
Trauma or previous surgery of the extremity
Open or pathological fracture
Vascular or neurological injury associated
Unable to collaborate with rehabilitation
Patients with serious comorbidities that discourage surgery
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Carlos Torrens, PhD
Organizational Affiliation
Parc de Salut Mar
Official's Role
Study Director
Facility Information:
Facility Name
Joan Miquel Noguera
City
Collbató
State/Province
Barcelona
ZIP/Postal Code
08293
Country
Spain
12. IPD Sharing Statement
Citations:
PubMed Identifier
35727196
Citation
Handoll HH, Elliott J, Thillemann TM, Aluko P, Brorson S. Interventions for treating proximal humeral fractures in adults. Cochrane Database Syst Rev. 2022 Jun 21;6(6):CD000434. doi: 10.1002/14651858.CD000434.pub5.
Results Reference
derived
Learn more about this trial
Reverse Or Nothing For Complex Proximal Humeral Fractures
We'll reach out to this number within 24 hrs